U.S. Computer-Aided Detection (CAD) Market Size to Exceed USD 2,259.6 Mn by 2032

The U.S. Computer-Aided Detection (CAD) Market, estimated at USD 892.0 Mn in 2025, is expected to exhibit a CAGR of 14.2% and reach USD 2,259.6 Mn by 2032.

Market expansion is fueled by growing adoption of digital healthcare solutions, rising demand for efficient data management, and continuous advancements in health IT infrastructure. Increasing integration of electronic health records (EHRs), telehealth platforms, and AI-driven analytics is enhancing patient care, operational efficiency, and decision-making. Strategic collaborations, evolving business models, and supportive regulatory frameworks are creating strong growth prospects for both emerging players and established healthcare IT providers.

Increase in the prevalence of cardiovascular diseases is expected to grow the market over the forecast period. For instance, in June 2025, a data was published by World Health Organization (WHO), according to that cardiovascular diseases (CVDs) are the leading cause of death. An estimated 17.9 million people died from CVDs in 2025, representing 32% of all deaths. Of these deaths, 85% were due to heart attack and stroke.

U.S. Computer-Aided Detection (CAD) Market– Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.

COVID-19 positively affected the market as the increasing demand for the detection equipment was increased during the pandemic.

U.S. Computer-Aided Detection (CAD) Market: Key Developments

Increasing launch of products is expected to drive the market over the forecast period. For instance, in March 2025, Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced the full U.S. commercial availability of the Shockwave L6 Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration (FDA). The Shockwave L6 catheter is purpose-built to modify calcification in otherwise difficult-to-treat lesions in large peripheral vessels, including the iliac and the common femoral arteries.

Browse 27 Market Data Tables and 22 Figures spread through 157 Pages and in-depth TOC on “U.S. Computer-Aided Detection (CAD) Market”- Forecast to 2032, U.S. Computer-Aided Detection (CAD) Market, , by Product Type (Breast CAD,  Abdominal CAD, Prostrate CAD, Cardiovascular CAD, Others), by Imaging Modality (Mammography, X-Ray Imaging, MRI, Computed Tomography, Ultrasound, Others)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/us-computer-aided-detection-cad-market-3292

Key Takeaways of the U.S. Computer-Aided Detection (CAD) Market:

• The U.S. computer-aided detection (CAD) market is expected to exhibit a CAGR of 14.2% during the forecast period due to the increasing inorganic strategies such as acquisitions by the key players. For instance, in February 2025, Abbott, a medical device manufacturing company and Cardiovascular Systems, Inc., a medical device company, announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
• Among product type, breast CAD segment is estimated to hold a dominant position in the U.S. computer-aided detection (CAD) market over the forecast period.
• Major players operating in the U.S. computer-aided detection (CAD) market include iCAD, Inc., Koninklijke Philips N.V., Holojic, Inc., Carestream Health, Inc., Siemens AG, GE Healthcare, EDDA Technology, Inc., EDDA Technology, Inc., and other prominent players.